Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
Biochemistry|September 8, 2004
Topology scanning and putative three-dimensional structure of the extracellular binding domains of the apical sodium-dependent bile acid transporter (SLC10A2)Eric Y Zhang, Mitch A Phelps, Antara Banerjee, et al.The Journal of Biological Chemistry|June 8, 2007
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family membersGregory Kaler, David M Truong, Akash Khandelwal, et al.Journal of Medicinal Chemistry|July 9, 2004
A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptorCasey E Bohl, Cheng Chang, Michael L Mohler, et al.American Journal of Respiratory Cell and Molecular Biology|January 1, 2005
Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epitheliumPraveen M Bahadduri, Vanessa M D'Souza, Julia K Pinsonneault, et al.Journal of Pharmaceutical Sciences|November 16, 2002
Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skinAudra L Stinchcomb, Peter W Swaan, Opinya Ekabo, et al.Molecular Pharmacology|June 15, 2007
Dynamin 2 regulates riboflavin endocytosis in human placental trophoblastsAmy B Foraker, Abhijit Ray, Tatiana Claro Da Silva, et al.Journal of Lipid Research|July 29, 2020
Quantification of common and planar bile acids in tissues and cultured cellsStephanie J Shiffka, Jace W Jones, Linhao Li, et al.Pharmaceutical Research|December 10, 2003
Structural determinants of P-glycoprotein-mediated transport of glucocorticoidsCharles R Yates, Cheng Chang, Jeffrey D Kearbey, et al.Molecular Pharmacology|April 27, 2017
Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane ReceptorBryan Mackowiak, Linhao Li, Matthew A Welch, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 25, 2013
Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4Kathleen Köck, Brian C Ferslew, Ida Netterberg, et al.Pageof 10